Selpercatinib (Retevmo)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Selpercatinib (Retevmo), covering 2025-09-16 to 2025-09-16. Get the full timeline:
Most recent: Clinical Trial Update: A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants [Phase 1]